Publication | Closed Access

Thymoquinone administration ameliorates Alzheimer's disease-like phenotype by promoting cell survival in the hippocampus of amyloid beta1–42 infused rat model

Neurodegenerative DiseasesAlzheimer's DiseaseMedicineNeuropharmacologyRat ModelDegenerative PathologyNeuroprotectionNeurologyNeuroscienceNeurodegenerationAging-associated DiseaseAmyloid Beta1–42PharmacologyCell SurvivalProtective Mechanisms